Bioatla Inc Share Price

NASDAQ: BCAB

Small Cap

$0.77

(+-0.50%)

as on September 13, 2025 at 1:29 am IST

$₹

Bioatla Inc Stock Performance

as on September 13, 2025 at 1:29 am IST

Day's Low
Day's High
$0.75
Day's Price Range
$0.84
$0.77
2.60%
Downside
9.09%
Upside
52 Week's Low
52 Week's High
$0.24
52-Week Price Range
$2.53
$0.77
68.83%
Downside
227.92%
Upside

Bioatla Inc share price movements today

Previous Close: $0.77
Open: $0.79
Volume: 1.9M
Day's Low - High: $0.75 - $0.84
52 Week Low - High: $0.24 - $2.53

Bioatla Inc Historical Returns

1 Month Return: + 110.74 %
3 Month Return: + 91.1 %
1 Year Return: -57.19 %
3 Year Return: -90.94 %
5 Year Return: 0 %

Bioatla Inc Stock Fundamentals & Key Indicators

Check Bioatla Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$45.5M

EPS (TTM)

-1.1933

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

EBITDA

-62.5M

Revenue (TTM)

11.0M

Profit Margin

0.00%

Return On Equity TTM

265237000.00%

Bioatla Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Bioatla Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Bioatla Inc	BUY	$45.5M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$61.1B	256.98%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$101.1B	47.85%	28.07	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.4B	-3.43%	14.11	31.37%

Stock Returns calculator for Bioatla Inc Stock including INR - Dollar returns

The Bioatla Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Bioatla Inc investment value today

Current value as on today

₹47,680

Returns

₹52,320

(-52.32%)

Returns from Bioatla Inc Stock

₹57,459 (-57.46%)

Dollar Returns*

₹5,139 (+5.14%)

Analyst Recommendation on Bioatla Inc Stock

Based on 11 analysts

BUY

90.91%

Buy

9.09%

Hold

0.00%

Sell

Based on 11 analysts, 90.91% of analysts recommend a 'BUY' rating for Bioatla Inc. Average target price of $10

Bioatla Inc Share Price Target

Get share price movements and forecasts by analysts on Bioatla Inc.

What analysts predicted

92.3%UPSIDE

Target Price

$10

Current Price

$0.77

Analyzed by

11 Analysts

Target

$10.00

Bioatla Inc target price $10, a slight upside of 92.3% compared to current price of $0.77. According to 11 analysts rating.

Bioatla Inc Stock's Interest Amongst Investors

Search interest for Bioatla Inc Stock has increased by 211% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 16, 2025 to September 15, 2025

Change:211% versus previous 30 day period

Bioatla Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	1	-	-	11	-	-	-
Gross Profit	0	0	0	0	0	0	10	0	0	0
Operating Income	-28	-37	-35	-28	-24	-21	-11	-16	-17	-18
EBITDA	-28	-36	-34	-28	-24	-21	-11	-16	-17	-18
Interest Expense	1	-	-	1	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-27	-35	-33	-26	-23	-21	-10	-14	-15	-18
Income Tax Expense	-1	-1	-2	4	0	-	-	-	-	-
Net Income	-25	-35	-33	-26	-23	-21	-10	-14	-15	-18
Net Profit Margin	0.00%	0.00%	0.00%	-1578.25%	0.00%	0.00%	-96.24%	0.00%	0.00%	0.00%

Bioatla Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	10	5	0	0	-	-	11
Gross Profit	-15	5	-19	-1	-1	-1	10
Operating Income	-28	-28	-30	-96	-108	-129	-73
EBITDA	-27	-27	-33	-94	-105	-122	-73
Interest Expense	0	1	1	0	1	-	-
Depreciation	0	0	1	1	1	1	0
Income Before Tax	-28	-29	-35	-95	-106	-123	-69
Income Tax Expense	0	1	1	0	-1	-	-
Net Income	-28	-29	-35	-95	-105	-123	-69
Net Profit Margin	-272.69%	-574.13%	-8357.34%	-38162.40%	0.00%	0.00%	-634.33%

Bioatla Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-35	-33	-26	-23	-21	-10	-14	-15	-18
Operating Cash Flow	-24	-27	-29	-30	-19	-5	-16	-16	-14
Investing Cash Flow	0	0	0	-	-	-	-	-	-
Financing Cash Flow	0	0	0	0	0	0	9	0	0
Change in Cash	-23	-27	-29	-30	-18	-5	-7	-16	-14

Bioatla Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-29	-35	-95	-106	-123	-69
Operating Cash Flow	-9	-36	-62	-90	-104	-71
Investing Cash Flow	-1	0	0	0	0	-
Financing Cash Flow	3	271	69	61	0	9
Change in Cash	-7	234	6	-29	-104	-62

Global Institutional Holdings in Bioatla Inc

Funds	Holdings
Vanguard Group Inc	3.11%
Acadian Asset Management LLC	2.89%
TANG CAPITAL MANAGEMENT LLC	2.35%
Renaissance Technologies Corp	1.27%
Morgan Stanley - Brokerage Accounts	1.02%

See all

Insights on Bioatla Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 1 month, BCAB stock has moved up by 110.7%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 123.5% return, outperforming this stock by 214.4%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.6% return, outperforming this stock by 132.8%

About Bioatla Inc

bioatla is a protein therapeutic company that uses discovery and evolution to develop safer and more potent drugs for the treatment of cancer. the culmination of our discovery and evolution expertise and more than 150 issued patents and patent applications is our conditionally active biologics (cab) platform, whereby monoclonal antibodies or other biologics can be engineered for selective conditional activation, for example preferential binding under the unique conditions of the tumor microenvironment. this improvement in tumor selectivity helps address the issue of on-target toxicity and improve therapeutic index. bioatla is applying these technologies in our own pipeline and in partnerships to ultimately deliver better immunotherapies for cancer.

Organisation	Bioatla Inc
Headquarters	11085 Torreyana Road, San Diego, CA, United States, 92121
Industry	Healthcare
CEO	Dr. Jay M. Short Ph.D.
E-voting on shares	Click here to vote

Key Management of Bioatla Inc

Name	Title
Dr. Eric L. Sievers M.D.	Chief Medical Officer
Ms. Susie Melody	Senior Vice President of Human Resources
Dr. Gerhard Frey Ph.D.	Senior Vice President of Technology Development
Ms. Sheri Lydick	Chief Commercial Officer
Lisa M. Pelton	Accounting Manager
Dr. Jay M. Short Ph.D.	Co-Founder, CEO & Chairman
Mr. Richard A. Waldron	Senior VP & CFO
Mr. Christian J. Vasquez CPA	Chief Accounting Officer, Controller and Corporate Secretary
Dr. Cathy Chang Ph.D.	Senior Vice President of Research & Development
Ms. Monica Sullivan	Senior Vice President of Intellectual Property & Contracts

FAQs

What is Bioatla Inc share price today?

Bioatla Inc share price today is $0.77 as on September 13, 2025 at 1:29 am IST at the close of the market. Bioatla Inc share today touched a day high of $0.84 and a low of $0.75.

What is the 52 week high and 52 week low for Bioatla Inc share?

Bioatla Inc share touched a 52 week high of $2.53 on November 11, 2024 and a 52 week low of $0.24 on March 4, 2025. Bioatla Inc stock price today i.e. September 13, 2025 at 1:29 am IST is closed at $0.77,which is 69.50% down from its 52 week high and 220.83% up from its 52 week low.

What is Bioatla Inc's market capitalisation today?

Bioatla Inc market capitalisation is $0.00T as on September 13, 2025 at 1:29 am IST.

How to invest in Bioatla Inc Stock (BCAB) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Bioatla Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Bioatla Inc Shares that will get you 1.9481 shares as per Bioatla Inc share price of $0.77 per share as on September 13, 2025 at 1:29 am IST.

What is the minimum amount required to buy Bioatla Inc Stock (BCAB) from India?

Indian investors can start investing in Bioatla Inc (BCAB) shares with as little as ₹88.27 or $1 (as of September 15, 2025 at 4:44 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹882.70 in Bioatla Inc stock (as per the Rupee-Dollar exchange rate as on September 15, 2025 at 4:44 pm IST). Based on Bioatla Inc share’s latest price of $0.77 as on September 13, 2025 at 1:29 am IST, you will get 12.9870 shares of Bioatla Inc. Learn more about fractional shares .